FrançaisAre analysts right about Omnicell (OMCL)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Omnicell, we replayed every analyst price target of the past 12 months and measured the real outcome: 36% were profitable, average return -2% (75 calls). At 3 months: -1% average return (47% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Benchmark | 19 | 37% | +2% |
| Piper Sandler | 11 | 46% | -5% |
| Wells Fargo | 10 | 40% | -4% |
| Keybanc | 7 | 0% | -50% |
| Cantor Fitzgerald | 6 | 67% | +52% |
Frequently asked questions
Is Omnicell a buy right now?
The analyst consensus on Omnicell (OMCL) is "Buy" (11 bullish, 0 bearish calls over 12 months). This is not advice: historically, 36% of their targets on this stock turned out profitable over 1 year.
What is Omnicell's price target?
The median 12-month price target is $50.00 (+50% vs $33.41), ranging from $45.00 to $65.00 (3 analysts).
Are analysts accurate on Omnicell?
Over 1 year, 36% of analyst targets on Omnicell were profitable, for an average return of -2% (across 75 timestamped calls). This is JPI Invest's accuracy metric.
What is the Omnicell stock forecast?
Analysts target a median of $50.00 within 12 months, i.e. +50% vs the current price. The most bullish targets $65.00, the most cautious $45.00.
What is the Omnicell stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $50.00, +50%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (36%), and the stock's past trajectory.
Is Omnicell overvalued?
Detailed valuation data for Omnicell is available in the interactive analysis.
📊 See the full interactive analysis of Omnicell →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.